Search results
May 5, 2023 · Reclast is a drug that can treat and prevent osteoporosis by reducing bone loss and promoting bone formation. A person receives a reclast infusion via an intravenous infusion (IV) into a...
Reclast injection must be administered as an intravenous infusion over no less than 15 minutes. Patients must be appropriately hydrated prior to administration of Reclast [seeWarnings and Precautions (5.3)].
Nov 1, 2023 · Zoledronic acid (Reclast), an annual IV infusion Another common osteoporosis medication is denosumab (Prolia, Xgeva). Unrelated to bisphosphonates, denosumab might be used in people who can't take a bisphosphonate, such as some people with reduced kidney function.
Jan 3, 2023 · How it works. Reclast is a brand (trade) name for zoledronic acid which may be used to strengthen bones and to treat or prevent osteoporosis. Reclast (zoledronic acid) works by inhibiting osteoclasts which are responsible for breaking down and reabsorbing bone (by a process known as bone resorption).
Zoledronic acid is given once a year as an intravenous (IV) infusion to treat osteoporosis. It is also given every two years as an IV infusion to prevent osteoporosis. Zoledronic acid increases bone density and reduces the incidence of the spine and non-spine fractures, including hip fractures.
Reclast® (RE-clast) (zoledronic acid) Injection. Read the Medication Guide that comes with Reclast before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or treatment.
What is this medication? ZOLEDRONIC ACID (ZOE le dron ik AS id) slows calcium loss from bones. It treats Paget's disease and osteoporosis. It may be used in other people at risk for bone loss. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
